Brainstorm Cell Therapeutics In

Historical 13F Holders

Symbol
BCLI
CUSIP
10501E201
All holders as of
Q4 2024
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q4 3 38.4 k $87.2 k
2024 Q3 40 10.8 M $2.49 M
2024 Q2 55 12.3 M $4.10 M
2024 Q1 54 4.12 M $2.16 M
2023 Q4 55 4.01 M $1.05 M
2023 Q3 61 4.79 M $899 k
2023 Q2 66 5.72 M $10.9 M
2023 Q1 56 6.36 M $20.4 M
2022 Q4 52 3.79 M $6.31 M
2022 Q3 49 3.87 M $17.1 M
2022 Q2 53 3.97 M $11.0 M
2022 Q1 46 4.16 M $15.3 M
2021 Q4 50 4.40 M $17.6 M
2021 Q3 61 5.13 M $16.9 M
2021 Q2 65 5.63 M $21.4 M
2021 Q1 88 8.43 M $32.3 M
2020 Q4 107 8.70 M $40.4 M
2020 Q3 96 6.81 M $115 M
2020 Q2 90 6.25 M $70.1 M
2020 Q1 61 3.71 M $17.2 M
2019 Q4 50 2.21 M $9.46 M
2019 Q3 43 2.12 M $8.24 M
2019 Q2 45 2.09 M $8.24 M
2019 Q1 43 2.41 M $10.5 M
2018 Q4 38 2.56 M $9.06 M
2018 Q3 40 2.37 M $9.04 M
2018 Q2 41 2.44 M $9.49 M
2018 Q1 36 1.71 M $5.38 M
2017 Q4 36 1.82 M $7.11 M
2017 Q3 36 1.63 M $6.72 M
2017 Q2 29 2.39 M $9.23 M
2017 Q1 27 1.03 M $4.38 M
2016 Q4 28 1.55 M $3.95 M
2016 Q3 26 1.31 M $3.14 M
2016 Q2 23 1.63 M $3.93 M
2016 Q1 28 1.70 M $4.52 M
2015 Q4 23 1.50 M $4.28 M
2015 Q3 24 2.32 M $5.31 M
2015 Q2 21 1.79 M $6.48 M
2015 Q1 21 2.41 M $10.7 M
2014 Q4 12 103 k $488 k
2014 Q3 7 917 k $3.78 M